TAMOXIFEN CITRATE (NOLVADEX) (20 MG/TAB. – 50 TABS)

£23.00

+ Free Shipping

Tamoxifen citrate 20 is a nonsteroidal agent that has demonstrated potent antiestrogenic
effects related to its ability to compete with estrogen for binding sites in target tissues.
Tamoxifen citrate is an oral anti- estrogen and estrogen antagonist which competes with
estrogen at the receptor sites reducing estrogenic expression. Tamoxifen citrate is a
Selective Estrogen Receptor Modular (SERM) acting via estrogen site competition as
opposed to Aromatase Inhibitor (Al) drugs which prevent aromatase derived estrogens from
being created.

Category:

Tamoxifen Citrate (Nolvadex) 20 mg/Tablets – 50 Tablets: UK Product Information

Overview

Tamoxifen citrate is a selective oestrogen receptor modulator (SERM) used in certain areas of breast cancer treatment and prevention. It works by interacting with oestrogen receptors and can reduce the effects of oestrogen in particular tissues.

The stated presentation contains 20 mg per tablet with 50 tablets in the package. This describes the labelled strength and quantity only. It should not be interpreted as a recommended dose, treatment schedule, or instruction for personal use.

For UK readers, tamoxifen should be distinguished from dietary supplements and medicines obtained through unregulated online sources. Appropriate use depends on an individual’s medical circumstances and professional assessment.

What Is Tamoxifen Citrate?

Tamoxifen is a non-steroidal SERM. Rather than simply lowering oestrogen throughout the body, it produces different effects depending on the tissue involved.

In breast tissue, tamoxifen can block oestrogen receptor activity. This mechanism is particularly relevant to certain hormone-sensitive breast cancers, where oestrogen can contribute to the growth of cancer cells.

Nolvadex is a brand name historically associated with tamoxifen. However, a brand name or online product listing does not independently establish authenticity, manufacturing quality, regulatory status, or suitability for an individual.

20 mg/Tablets – 50 Tablets

The stated presentation contains 20 mg per tablet, with 50 tablets in the package. If every tablet contains the labelled strength, the complete package represents a nominal 1,000 mg of tamoxifen citrate.

This calculation explains the stated product specification only. It does not establish how much an individual should take or how long treatment should continue.

When evaluating a medicine, relevant information includes the active ingredient, strength, manufacturer, batch or lot number, expiry date, packaging integrity, storage requirements, excipients, and official product documentation.

Medical Uses

Tamoxifen is primarily associated with the management of certain types of breast cancer. It may be used in people with hormone receptor-positive disease, depending on factors such as menopausal status, cancer characteristics, previous treatments, and the overall treatment plan.

It may also have a role in reducing breast cancer risk for selected individuals under specialist medical guidance.

Treatment decisions are individualised. The appropriate medicine, duration of treatment, and monitoring requirements depend on the diagnosis and the recommendations of the patient’s oncology or healthcare team.

Tamoxifen should not be presented as a general-purpose hormone-balancing product or as an appropriate treatment for bodybuilding-related hormonal effects.

How It Works

Tamoxifen binds to oestrogen receptors and modifies the way oestrogen signals are transmitted in different tissues. In breast tissue, its anti-oestrogenic activity can interfere with oestrogen-dependent signalling.

Its effects are tissue-specific, which is an important distinction when explaining how selective oestrogen receptor modulators work.

Because tamoxifen affects hormone signalling, its use should be based on an appropriate medical indication rather than assumptions about its effects on body composition or hormone levels.

Potential Side Effects

Tamoxifen can cause adverse effects. Some people may experience hot flushes, sweating, nausea, fatigue, mood changes, or menstrual changes.

More serious complications can occur, although they are less common. These include blood clots and certain changes affecting the uterus. Any unusual vaginal bleeding should be medically assessed.

Symptoms such as sudden chest pain, difficulty breathing, coughing blood, or swelling and pain in a leg require urgent medical attention because they may indicate a serious blood-clotting problem.

Patients should discuss their complete medical history and current medicines with their healthcare professional before treatment.

Drug Interactions and Monitoring

Tamoxifen can interact with other medicines. Certain medicines that affect the CYP2D6 enzyme may influence the way tamoxifen is metabolised and can potentially affect treatment.

Patients should provide their doctor or pharmacist with a complete list of prescription medicines, non-prescription products, and supplements they use.

Monitoring requirements depend on the reason for treatment and the individual’s health circumstances. Patients should follow their prescribed treatment plan and should not independently change the amount or duration of therapy.

Product Verification

Reliable documentation is important when evaluating any medicine. Useful information includes the active ingredient, tablet strength, manufacturer, batch number, expiry date, packaging details, storage requirements, and appropriate regulatory information.

Online photographs, reviews, brand names, and promotional claims cannot independently confirm authenticity.

Medicines obtained from unregulated sources may contain incorrect ingredients, inaccurate strengths, contaminants, or substances that are not declared on the label. A pharmacist can provide appropriate guidance when the identity or quality of a medicine is uncertain.

UK Regulatory Considerations

UK readers should obtain prescription medicines through legitimate healthcare and pharmacy channels. The Medicines and Healthcare products Regulatory Agency (MHRA) provides regulatory oversight and medicine-safety information in the United Kingdom.

Online availability does not demonstrate that a medicine is authorised, genuine, or suitable for a particular person.

Responsible UK SEO content should avoid presenting prescription medicines as ordinary supplements or guaranteeing health outcomes. Accurate information should distinguish established medical indications from unsupported claims circulating online.

Responsible SEO Information

A strong UK-focused page can establish topical relevance without repeatedly using the same commercial phrase. Related terms may include tamoxifen citrate, Nolvadex, selective oestrogen receptor modulator, SERM, 20 mg tablets, 50-tablet presentation, breast cancer treatment, hormone receptor-positive cancer, prescription medicine, UK pharmacy, medicine safety, and product verification.

Natural semantic variation improves readability while avoiding keyword stuffing. Clear headings, accurate specifications, and transparent medical information can provide greater value to visitors and support quality-focused search optimisation.

Product Summary

Tamoxifen Citrate (Nolvadex) 20 mg/Tablets – 50 Tablets describes a tablet presentation containing a stated strength of 20 mg per tablet and 50 tablets in the package. Assuming the labelled strength is accurate, the nominal total quantity is 1,000 mg of tamoxifen citrate.

The stated strength and package size do not determine whether treatment is medically appropriate for an individual.

This page provides factual medical and regulatory information only. It does not recommend self-administration, provide a personal treatment regimen, or encourage non-prescribed use.

TAMOXIFEN CITRATE (NOLVADEX) (20 MG/TAB. – 50 TABS)TAMOXIFEN CITRATE (NOLVADEX) (20 MG/TAB. – 50 TABS)

Reviews

There are no reviews yet.

Be the first to review “TAMOXIFEN CITRATE (NOLVADEX) (20 MG/TAB. – 50 TABS)”

Your email address will not be published. Required fields are marked *

Shopping Cart